TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/11/24 20:00 | 10/11/24 | WVE | Wave Life Sciences Ltd. | U0 | Health | Drug | Pharmaceutical Preparations | Moran Kyle | MA | O | CFO | M.d | 62 | 2.48 | 0 | 25 | 126 | 45 | D | ||||||||||||||
9/27/24 20:00 | 9/25/24 | WVE | Wave Life Sciences Ltd. | U0 | Health | Drug | Pharmaceutical Preparations | Moran Kyle | MA | O | CFO | S | -154 | 9.00 | 0 | -17 | -46 | 20 | D | ||||||||||||||
4/5/24 20:00 | 4/3/24 | WVE | Wave Life Sciences Ltd. | U0 | Health | Drug | Pharmaceutical Preparations | Moran Kyle | MA | O | CFO | S | -96 | 6.17 | 0 | -16 | -32 | 34 | D | ||||||||||||||
8/23/23 21:15 | 8/23/23 | WVE | Wave Life Sciences Ltd. | U0 | Health | Drug | Pharmaceutical Preparations | Moran Kyle | MA | O | CFO | S | -176 | 4.75 | 0 | -37 | -45 | 46 | D | ||||||||||||||
2/17/23 20:00 | 2/16/23 | WVE | Wave Life Sciences Ltd. | U0 | Health | Drug | Pharmaceutical Preparations | Moran Kyle | MA | O | CFO | S.d | -39 | 4.04 | 0 | -10 | -11 | 80 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |